Financials

  • Market Capitalization 3.13 B
  • Employee 601
  • Founded 2015
  • CEO -
  • Website www.arcusbio.com
  • Headquarter Delaware, United States
  • FIGI BBG00DQD26W3
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-7.24
Rapporto prezzo/fatturato
10.36

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
1595
CELC
Celcuity Inc. - Common Stock
66.75 USD-1.75%-5.87%-19.92%+42.48%3.27 B USD
1622
AMLX
Amylyx Pharmaceuticals, Inc. - Common Stock
27.80 USD-1.21%+0.65%-12.69%+95.22%3.10 B USD
1639
DYN
Dyne Therapeutics, Inc. - Common Stock
16.21 USD-2.58%+5.12%-11.90%-30.76%3.03 B USD
1644
DNLI
Denali Therapeutics Inc. - Common Stock
19.07 USD-1.95%-3.83%-9.58%+17.93%3.05 B USD

Notizie